ACON News and Press, Aclarion Inc. From 01/08/24

Partnership aims to include Aclarion’s surgical decision support technology within ATEC’s AlphaInformatiX platform to better inform spine surgery Aclarion’s Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine to help physic...

2024-01-03 08:02:08 ET ACON (ACON) announced stock split at a ratio of 1-for-16 on 2024-01-04 ... Full story available on KlickAnalytics.com

2024-01-02 12:58:13 ET More on Aclarion, Inc. Financial information for Aclarion, Inc. For further details see: Aclarion announces reverse stock split

BROOMFIELD, CO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help phy...

2023-12-20 10:03:02 ET DENVER, Colo., Dec. 20, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Redhill Biopharma Ltd (NASDAQ: RDHL), LQR House Inc (NASDAQ: LQR), Siyata Mobile Inc (NASDAQ: SYTA), Aclarion...

2023-12-12 07:39:07 ET More on Aclarion, Inc. Financial information for Aclarion, Inc. For further details see: Aclarion files to sell 25.93M units

Pace of Nociscan orders accelerated 2.5x for the last 250 scans compared to the first 250 scans Further acceleration of scan volumes expected as MRIs are activated for the recently completed panel of 10 Key Opinion Leader (KOL) surgeons All commercial Nociscans to date have been completed...

Recruitment of a panel of leading KOL surgeons who believe Nociscan can improve the diagnosis and treatment of discogenic low back pain is a critical step to establishing Nociscan as standard of care. Aclarion’s KOL panel represents spine surgeons at some of the largest and most influe...

Dr. Hartl is the Hansen-MacDonald Professor of Neurological Surgery and Director of Spinal Surgery at the Weill Cornell Brain and Spine Center in New York, and the co-director of New York-Presbyterian Och Spine. Dr. Hartl becomes Aclarion’s 2 nd KOL to get access to an MRI center a...

The Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, is funding ground-breaking low back pain research. The Back Pain Consortium (BACPAC) Research Program, a recipient of the NIH HEAL Initiative, is an effort to address the need for effective and personalized...